Interparfums, Inc. (IPAR)
(Delayed Data from NSDQ)
$121.69 USD
+0.62 (0.51%)
Updated Nov 1, 2024 03:59 PM ET
After-Market: $121.49 -0.20 (-0.16%) 7:58 PM ET
1-Strong Buy of 5 1
D Value B Growth D Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$121.69 USD
+0.62 (0.51%)
Updated Nov 1, 2024 03:59 PM ET
After-Market: $121.49 -0.20 (-0.16%) 7:58 PM ET
1-Strong Buy of 5 1
D Value B Growth D Momentum C VGM
Zacks News
Inter Parfums (IPAR) Down 19.3% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Inter Parfums (IPAR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Yes, You Can Time the Market. Find out How - March 25, 2020
by Zacks Equity Research
Have you ever dreamed of being that one in a million investor who has the talent to perfectly time the markets?
Inter Parfums (IPAR) Withdraws 2020 View Due to Coronavirus
by Zacks Equity Research
Due to the coronavirus outbreak and its impact on revenues and costs, Inter Parfums (IPAR) has withdrawn full-year 2020 guidance.
Ulta Beauty Enhances Financial Flexibility Amid Coronavirus
by Zacks Equity Research
Ulta Beauty (ULTA) announces that it has drawn down $800 million under its revolving credit facility in order to maintain financial flexibility amid the coronavirus outbreak.
Will Nu Skin Mainland China Woes Worsen Due to Coronavirus?
by Zacks Equity Research
Nu Skin (NUS) anticipates sales in Mainland China to decline 20-25% in 2020. The company puts meetings on hold in the region due to the coronavirus outbreak.
Coronavirus Steals Glitter Off These 3 Cosmetic Stocks
by Vrishali Bagree
Coronavirus-led worries weigh on the guidance of these cosmetic stocks due to reduced global travel and sluggish traffic.
Inter Parfums (IPAR) Q4 Earnings Meet Estimates, View Down
by Zacks Equity Research
Inter Parfums' (IPAR) Q4 results benefit from growth in U.S.-based operations. However, outbreak of coronavirus is likely to impact the company's performance in 2020.
Inter Parfums (IPAR) Q4 Earnings Match Estimates
by Zacks Equity Research
Inter Parfums (IPAR) delivered earnings and revenue surprises of 0.00% and 0.00%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
Timing the Market, Is it Possible? - February 28, 2020
by Zacks Equity Research
In the long-run, does consistent market timing really matter to be a successful investor?
Factors Setting the Tone for Inter Parfums (IPAR) Q4 Earnings
by Zacks Equity Research
Strength in U.S. based operations is likely to get reflected in Inter Parfums' (IPAR) Q4 earnings.
Inter Parfums (IPAR) to Report Q4 Results: What You Should Expect
by Zacks Equity Research
Inter Parfums (IPAR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Nu Skin's (NUS) Q4 Earnings Meet Estimates, Down Year on Year
by Zacks Equity Research
Nu Skin's (NUS) fourth-quarter 2019 results reflect lower earnings and sales. Further, management expects the coronavirus outbreak to hurt Mainland China sales in 2020.
How to Time the Markets Like an Investing Pro - February 04, 2020
by Zacks Equity Research
Is the ability to time the markets more of a data-driven science or a 'gut - feeling' art?
Inter Parfums (IPAR) Posts Sales Numbers for Q4 & 2019
by Zacks Equity Research
Inter Parfums (IPAR) reports record high sales in 2019. However, strong dollar and relatively fewer launches are concerns.
Simple Market Timing Strategies That Work - December 30, 2019
by Zacks Equity Research
Have you ever dreamed of being that one in a million investor who has the talent to perfectly time the markets?
4 Reasons Why Helen of Troy (HELE) Stock Appears Promising
by Zacks Equity Research
Helen of Troy's (HELE) robust online business and Leadership Brands bode well. Also, the Housewares segment is a key catalyst.
Timing the Market, Is it Possible? - December 11, 2019
by Zacks Equity Research
Is the ability to time the markets more of a data-driven science or a 'gut - feeling' art?
Inter Parfums (IPAR) Down 9.8% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Inter Parfums (IPAR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Yes, You Can Time the Market. Find out How - November 20, 2019
by Zacks Equity Research
Is the ability to time the markets more of a data-driven science or a 'gut - feeling' art?
International Flavors Rides on Favorable Demand, Costs High
by Zacks Equity Research
The global market for flavors and fragrances continues to grow fueled by rising demand for consumer products, which bodes well for the International Flavors & Fragrances (IFF).
Inter Parfums (IPAR) Misses on Q3 Earnings, Raises View
by Zacks Equity Research
Inter Parfums (IPAR) Q3 performance benefits from growth in European and U.S.-based operations.
Inter Parfums (IPAR) Lags Q3 Earnings Estimates
by Zacks Equity Research
Inter Parfums (IPAR) delivered earnings and revenue surprises of -1.49% and 0.01%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
FEMSA Comercio Seals JV with Raizen, Expands Brazil Footprint
by Zacks Equity Research
FEMSA Comercio, a unit of FEMSA (FMX), closes the previously entered JV agreement with Raizen Conveniencias in Brazil, after receiving the necessary regulatory approvals.
Things to Know Before Keurig Dr Pepper's (KDP) Q3 Earnings
by Zacks Equity Research
Changes in the Allied Brands portfolio and currency woes are likely to get reflected in Keurig Dr Pepper's (KDP) third-quarter sales. Higher operating income and lower debt might have aided earnings.
Factors Setting the Tone for Inter Parfums (IPAR) Q3 Earnings
by Zacks Equity Research
Inter Parfums (IPAR) Q3 earnings is likely to have gained from strength in U.S. and European-based operations.